OpenURL Connection Search

Select item for more details and to access through your institution.

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma.
Published in:
Pharmaceuticals (14248247), 2023, v. 16, n. 7, p. 995, doi. 10.3390/ph16070995
By:
- Giraudet, Anne Laure;
- Vinceneux, Armelle;
- Pretet, Valentin;
- Paquet, Emilie;
- Lajusticia, Alicia Sanchez;
- Khayi, Fouzi;
- Badel, Jean Noël;
- Boyle, Helen;
- Flechon, Aude;
- Kryza, David
Publication type:
Article
From netrin‐1‐targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors.
Published in:
EMBO Molecular Medicine, 2023, v. 15, n. 4, p. 1, doi. 10.15252/emmm.202216732
By:
- Kryza, David;
- Wischhusen, Jennifer;
- Richaud, Mathieu;
- Hervieu, Maëva;
- Sidi Boumedine, Jacqueline;
- Delcros, Jean‐Guy;
- Besse, Sophie;
- Baudier, Thomas;
- Laval, Pierre‐Alexandre;
- Breusa, Silvia;
- Boutault, Erwan;
- Clermidy, Hugo;
- Rama, Nicolas;
- Ducarouge, Benjamin;
- Devouassoux‐Shisheboran, Mojgan;
- Chezal, Jean‐Michel;
- Giraudet, Anne‐Laure;
- Walter, Thomas;
- Mehlen, Patrick;
- Sarrut, David
Publication type:
Article
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
Published in:
2018
By:
- Giraudet, Anne-Laure;
- Cassier, Philippe Alexandre;
- Iwao-Fukukawa, Chicaco;
- Garin, Gwenaelle;
- Badel, Jean-Noël;
- Kryza, David;
- Chabaud, Sylvie;
- Gilles-Afchain, Laurence;
- Clapisson, Gilles;
- Desuzinges, Claude;
- Sarrut, David;
- Halty, Adrien;
- Italiano, Antoine;
- Mori, Masaharu;
- Tsunoda, Takuya;
- Katagiri, Toyomasa;
- Nakamura, Yusuke;
- Alberti, Laurent;
- Cropet, Claire;
- Baconnier, Simon
Publication type:
journal article
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211053898
By:
- Giraudet, Anne-Laure;
- Kryza, David;
- Hofman, Michael;
- Moreau, Aurélie;
- Fizazi, Karim;
- Flechon, Aude;
- Hicks, Rodney J.;
- Tran, Ben
Publication type:
Article
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211053898
By:
- Giraudet, Anne-Laure;
- Kryza, David;
- Hofman, Michael;
- Moreau, Aurélie;
- Fizazi, Karim;
- Flechon, Aude;
- Hicks, Rodney J.;
- Tran, Ben
Publication type:
Article
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 11, p. 4185, doi. 10.1210/jc.2007-1211
By:
- Giraudet, Anne Laure;
- Vanel, Daniel;
- Leboulleux, Sophie;
- Aupérin, Anne;
- Dromain, Clarisse;
- Chami, Linda;
- Tovo, Noël Ny;
- Lumbroso, Jean;
- Lassau, Nathalie;
- Bonniaud, Guillaume;
- Hartl, Dana;
- Travagli, Jean-Paul;
- Baudin, Eric;
- Schlumberger, Martin
Publication type:
Article
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
Published in:
BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-023-11702-8
By:
- Kryza, David;
- Vinceneux, Armelle;
- Bidaux, Anne-Sophie;
- Garin, Gwenaelle;
- Tatu, Delphine;
- Cropet, Claire;
- Badel, Jean-Noël;
- Perol, David;
- Giraudet, Anne-Laure
Publication type:
Article
Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for 177Lu-DOTATATE therapy.
Published in:
EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00462-2
By:
- Vergnaud, Laure;
- Giraudet, Anne-Laure;
- Moreau, Aurélie;
- Salvadori, Julien;
- Imperiale, Alessio;
- Baudier, Thomas;
- Badel, Jean-Noël;
- Sarrut, David
Publication type:
Article
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
Published in:
European Journal of Endocrinology, 2014, v. 170, n. 4, p. 575, doi. 10.1530/EJE-13-0825
By:
- Massicotte, Marie-Hélene;
- Brassard, Maryse;
- Claude-Desroches, Médéric;
- Borget, Isabelle;
- Bonichon, Françoise;
- Giraudet, Anne-Laure;
- Do Cao, Christine;
- Chougnet, Cécile N.;
- Leboulleux, Sophie;
- Baudin, Eric;
- Schlumberger, Martin;
- de la Fouchardière, Christelle
Publication type:
Article
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?
Published in:
EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00658-8
By:
- Vergnaud, Laure;
- Dewaraja, Yuni K.;
- Giraudet, Anne-Laure;
- Badel, Jean-Noël;
- Sarrut, David
Publication type:
Article
Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment.
Published in:
EJNMMI Physics, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40658-023-00576-1
By:
- Vergnaud, Laure;
- Badel, Jean-Noël;
- Giraudet, Anne-Laure;
- Kryza, David;
- Mognetti, Thomas;
- Baudier, Thomas;
- Rida, Hanan;
- Dieudonné, Arnaud;
- Sarrut, David
Publication type:
Article
F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 8, p. 1206, doi. 10.1007/s00259-013-2405-z
By:
- Champion, Laurence;
- Lerebours, Florence;
- Cherel, Pascal;
- Edeline, Veronique;
- Giraudet, Anne-Laure;
- Wartski, Myriam;
- Bellet, Dominique;
- Alberini, Jean-Louis
Publication type:
Article
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 3, p. 450, doi. 10.1007/s00259-011-1981-z
By:
- Mortazavi-Jehanno, Nina;
- Giraudet, Anne-Laure;
- Champion, Laurence;
- Lerebours, Florence;
- Stanc, Elise;
- Edeline, Veronique;
- Madar, Olivier;
- Bellet, Dominique;
- Pecking, Alain;
- Alberini, Jean-Louis
Publication type:
Article
3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma.
Published in:
EJNMMI Physics, 2017, v. 4, n. 1, p. 1, doi. 10.1186/s40658-016-0172-1
By:
- Sarrut, David;
- Badel, Jean-Noël;
- Halty, Adrien;
- Garin, Gwenaelle;
- Perol, David;
- Cassier, Philippe;
- Blay, Jean-Yves;
- Kryza, David;
- Giraudet, Anne-Laure
Publication type:
Article
Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 579, doi. 10.2967/jnumed.122.264743
By:
- Olivier, Pierre;
- Giraudet, Anne-Laure;
- Skanjeti, Andrea;
- Merlin, Charles;
- Weinmann, Pierre;
- Rudolph, Ines;
- Hoepping, Alexander;
- Gauthé, Mathieu
Publication type:
Article
Phase II study of 131I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.
Published in:
Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30615
By:
- Sevrin, François;
- Kolesnikov‐Gauthier, Hélène;
- Cougnenc, Olivier;
- Bogart, Emilie;
- Schleiermacher, Gudrun;
- Courbon, Frederic;
- Gambart, Marion;
- Giraudet, Anne‐Laure;
- Corradini, Nadège;
- Badel, Jean‐Noël;
- Rault, Erwann;
- Oudoux, Aurore;
- Deley, Marie Cécile Le;
- Valteau‐Couanet, Dominique;
- Defachelles, Anne‐Sophie
Publication type:
Article
Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network.
Published in:
Endocrine (1355008X), 2021, v. 72, n. 3, p. 798, doi. 10.1007/s12020-020-02580-2
By:
- BONICHON, Françoise;
- de BAERE, Thierry;
- Berdelou, Amandine;
- Leboulleux, Sophie;
- Giraudet, Anne-Laure;
- Cuinet, Marie;
- Drui, Delphine;
- Liberge, Renan;
- Kelly, Antony;
- Tenenbaum, Florence;
- Legmann, Paul;
- Do Cao, Christine;
- Leenhardt, Laurence;
- Toubeau, Michel;
- Godbert, Yann;
- Palussière, Jean
Publication type:
Article
Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.
Published in:
2016
By:
- Fouchardiere, Christelle;
- Oussaid, Nadia;
- Derbel, Olfa;
- Decaussin-Petrucci, Myriam;
- Fondrevelle, Marie-Eve;
- Wang, Qing;
- Bringuier, Pierre-Paul;
- Bournaud-Salinas, Claire;
- Peix, Jean-Louis;
- Lifante, Jean-Christophe;
- Giraudet, Anne-Laure;
- Lopez, Jonathan;
- Borson-Chazot, Françoise;
- de la Fouchardiere, Christelle;
- Borson-Chazot, Françoise
Publication type:
journal article
Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
Published in:
2011
By:
- Champion L;
- Brain E;
- Giraudet AL;
- Le Stanc E;
- Wartski M;
- Edeline V;
- Madar O;
- Bellet D;
- Pecking A;
- Alberini JL;
- Champion, Laurence;
- Brain, Etienne;
- Giraudet, Anne-Laure;
- Le Stanc, Elise;
- Wartski, Myriam;
- Edeline, Véronique;
- Madar, Olivier;
- Bellet, Dominique;
- Pecking, Alain;
- Alberini, Jean-Louis
Publication type:
journal article
Breast cancer recurrence diagnosis suspected on tumor marker rising.
Published in:
Cancer (0008543X), 2011, v. 117, n. 8, p. 1621, doi. 10.1002/cncr.25727
By:
- Champion, Laurence;
- Brain, Etienne;
- Giraudet, Anne-Laure;
- Le Stanc, Elise;
- Wartski, Myriam;
- Edeline, Véronique;
- Madar, Olivier;
- Bellet, Dominique;
- Pecking, Alain;
- Alberini, Jean-Louis
Publication type:
Article
Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.
Published in:
Journal of Surgical Oncology, 2011, v. 103, n. 6, p. 602, doi. 10.1002/jso.21695
By:
- Alberini, Jean-Louis;
- Edeline, Veronique;
- Giraudet, Anne Laure;
- Champion, Laurence;
- Paulmier, Benoit;
- Madar, Olivier;
- Poinsignon, Anne;
- Bellet, Dominique;
- Pecking, Alain Paul
Publication type:
Article
Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 9, p. 2935, doi. 10.1007/s00259-020-05086-1
By:
- Chevalme, Yanna-Marina;
- Boudali, Lotfi;
- Gauthé, Mathieu;
- Rousseau, Caroline;
- Skanjeti, Andrea;
- Merlin, Charles;
- Robin, Philippe;
- Giraudet, Anne-Laure;
- Janier, Marc;
- Talbot, Jean-Noël
Publication type:
Article
Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 8, p. 1758, doi. 10.1007/s00259-019-04352-1
By:
- Moreau, Aurélie;
- Giraudet, Anne Laure;
- Mognetti, Thomas;
- Kryza, David
Publication type:
Article
Long-Term Efficacy of Radionuclide Therapy in Patients with Disseminated Neuroendocrine Tumors Uncontrolled by Conventional Therapy.
Published in:
Journal of Nuclear Medicine, 2004, v. 45, n. 10, p. 1660
By:
- Nguyen, Charles;
- Faraggi, Marc;
- Giraudet, Anne.-Laure;
- de Labriolle.-Vaylet, Claire;
- Aparicio, Thomas;
- Rouzet, François;
- Mignon, Michel;
- Askienazy, Serge;
- Sobhani, Iradj
Publication type:
Article

Found: 24

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma.

From netrin‐1‐targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors.

A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.

PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?

PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?

Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels.

A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).

Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for 177Lu-DOTATATE therapy.

Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.

A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?

Performance study of a 360° CZT camera for monitoring <sup>177</sup>Lu-PSMA treatment.

F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.

Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.

3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma.

Phase III Study of <sup>18</sup>F-PSMA-1007 Versus <sup>18</sup>F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study.

Phase II study of <sup>131</sup>I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.

Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network.

Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.

Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.

Breast cancer recurrence diagnosis suspected on tumor marker rising.

Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.

Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations.

Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [<sup>18</sup>F]-FDG PET/CT.

Long-Term Efficacy of Radionuclide Therapy in Patients with Disseminated Neuroendocrine Tumors Uncontrolled by Conventional Therapy.